bioAffinity Technologies Inc BIAF shares are trading lower Monday morning. The move follows a massive surge during Friday’s ...

Irvine-based Brand Affinity Technologies Inc., an advertising startup with technology that aims to automate celebrity endorsement deals, said Monday it bought La Jolla-based Beelya for undisclosed ...

bioAffinity Technologies Inc BIAF shares are trading higher on Tuesday morning. The move follows the release of a new clinical case study. The study highlights the benefits of adding CyPath Lung to ...

bioAffinity Technologies Inc BIAF shares are trading sharply higher Friday morning after the company reported full-year 2025 results highlighting strong growth in its flagship CyPath Lung diagnostic, ...

BioAffinity Technologies, Inc. (NASDAQ:BIAF) shares are trading lower by 50.7% to $1.48 during Wednesday’s session after the company announced a securities purchase agreement with institutional ...

Affinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a new clinical case study that ...

SAN ANTONIO, March 13, 2026--bioAffinity Technologies reports financial results for FY 2025, including record revenue and unit sales for the CyPath Lung test for lung cancer.

SAN ANTONIO, March 10, 2026--bioAffinity Technologies launches 2,000-patient longitudinal study for its CyPath Lung noninvasive diagnostic for lung cancer.